Published in Urology on June 22, 2010
Tumor biology and prognostic factors in renal cell carcinoma. Oncologist (2011) 1.62
The proliferation marker thymidine kinase 1 in clinical use. Mol Clin Oncol (2012) 0.94
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis. World J Gastroenterol (2012) 0.93
Thymidine kinase 1 upregulation is an early event in breast tumor formation. J Oncol (2012) 0.88
Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience (2015) 0.84
Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. Am J Cancer Res (2016) 0.80
Serum and urine biomarkers for human renal cell carcinoma. Dis Markers (2015) 0.80
Manganese superoxide dismutase in cancer prevention. Antioxid Redox Signal (2013) 0.77
Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma. BMC Urol (2015) 0.75
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 6.54
Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst (2004) 2.52
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews. Am J Hum Genet (2002) 2.24
A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications. Urology (2013) 2.19
Determination of renal stone composition with dual-energy CT: in vivo analysis and comparison with x-ray diffraction. Radiology (2010) 1.99
Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol (2006) 1.81
Robotic radical prostatectomy learning curve of a fellowship-trained laparoscopic surgeon. J Endourol (2007) 1.63
Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol (2002) 1.57
Watchful waiting policy in recurrent Ta G1 bladder tumors. Eur Urol (2006) 1.55
Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor. J Urol (2009) 1.55
The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. J Urol (2007) 1.50
Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. Eur Urol (2012) 1.50
Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One (2009) 1.46
Da Vinci robot error and failure rates: single institution experience on a single three-arm robot unit of more than 700 consecutive robot-assisted laparoscopic radical prostatectomies. J Endourol (2007) 1.45
Cancer risks in naval divers with multiple exposures to carcinogens. Environ Health Perspect (2003) 1.44
Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem (2008) 1.43
Heparanase promotes growth, angiogenesis and survival of primary breast tumors. Int J Cancer (2006) 1.42
X-ray diffraction and SEM study of kidney stones in Israel: quantitative analysis, crystallite size determination, and statistical characterization. Environ Geochem Health (2011) 1.40
[Update: adjuvant trastuzumab in HER2 positive breast cancer]. Harefuah (2012) 1.39
Bladder neck closure in children: a decade of followup. J Urol (2009) 1.37
The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcepsilonRI-activated mast cells. Immunity (2004) 1.36
Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation. Eur Urol (2006) 1.36
LysRS serves as a key signaling molecule in the immune response by regulating gene expression. Mol Cell (2009) 1.35
Role of endothelial heparanase in delayed-type hypersensitivity. Blood (2005) 1.35
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice. J Clin Invest (2011) 1.32
Function of heparanase in prostate tumorigenesis: potential for therapy. Clin Cancer Res (2008) 1.25
Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res (2003) 1.25
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A (2002) 1.23
Seminal vesicle cystadenoma: a rare clinical perspective. Eur Urol (2009) 1.22
Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Int J Cancer (2004) 1.18
Structural switch of lysyl-tRNA synthetase between translation and transcription. Mol Cell (2012) 1.17
Hemostatic agents and instruments in laparoscopic renal surgery. J Endourol (2008) 1.16
Mast cells and cancer--no longer just basic science. Crit Rev Oncol Hematol (2008) 1.14
Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J Biol Chem (2005) 1.13
Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene (2003) 1.12
Safety and efficacy of extracorporeal shock wave lithotripsy in infants. Can J Urol (2003) 1.11
Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutations. J Med Genet (2007) 1.09
Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res (2003) 1.09
Regeneration of myenteric plexus in the mouse colon after experimental denervation with benzalkonium chloride. J Comp Neurol (2003) 1.08
Lateral decubitus position for percutaneous nephrolithotripsy in the morbidly obese or kyphotic patient. J Endourol (2002) 1.08
Transcription factor MITF regulates cardiac growth and hypertrophy. J Clin Invest (2006) 1.07
Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood (2009) 1.07
A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J Biol Chem (2001) 1.06
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology (2007) 1.06
Is perceived family support a relevant variable in psychological distress?. A sample of prostate and breast cancer couples. J Psychosom Res (2003) 1.06
A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes? J Urol (2008) 1.04
Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area. Am J Surg (2004) 1.03
Bladder neck contracture after robot-assisted laparoscopic radical prostatectomy: evaluation of incidence and risk factors and impact on urinary function. J Endourol (2008) 1.03
Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. Arterioscler Thromb Vasc Biol (2003) 1.02
Primary and postoperative retroperitoneal fibrosis-experience with 18 cases. Urology (2002) 1.01
Clinical significance of urine heparanase in bladder cancer progression. Neoplasia (2008) 1.01
Is radical cystectomy mandatory in every patient with variant histology of bladder cancer. Rare Tumors (2011) 1.00
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy. Cancer Biol Ther (2011) 1.00
Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma. Cancer Res (2011) 1.00
An outbreak of achromobacter xylosoxidans associated with ultrasound gel used during transrectal ultrasound guided prostate biopsy. J Urol (2010) 0.99
beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor. PLoS One (2010) 0.99
Comparison of laparoscopic radical and partial nephrectomy: effects on long-term serum creatinine. Urology (2007) 0.98
The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response. Trends Immunol (2010) 0.98
Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol (2002) 0.98
Adult stentless laparoscopic pyeloplasty. JSLS (2007) 0.97
Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs. Cancer Res (2008) 0.97
Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age? Urology (2005) 0.97
Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (2013) 0.97
Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3. Cancer Res (2012) 0.96
Aortic occlusion in patients treated with Cisplatin-based chemotherapy. Mt Sinai J Med (2006) 0.95
Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? J Urol (2007) 0.94
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients. Med Oncol (2012) 0.94
A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer (2007) 0.94
Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy. Anticancer Res (2003) 0.94
Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J Immunol (2006) 0.94
Recovery of renal function after complete renal hilar versus artery alone clamping during open and laparoscopic surgery. J Urol (2007) 0.94
Continued improvement of perioperative, pathological and continence outcomes during 700 robot-assisted radical prostatectomies. Can J Urol (2009) 0.94
Embolization of renal-artery pseudoaneurysm after laparoscopic partial nephrectomy for angiomyolipoma: case report and literature review. J Endourol (2007) 0.93
Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis. Clin Transl Oncol (2012) 0.93
Planned nerve preservation to reduce positive surgical margins during robot-assisted laparoscopic radical prostatectomy. J Endourol (2008) 0.93
Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. Clin Cancer Res (2007) 0.92
The diagnostic and prognostic value of ProGRP in lung cancer. Anticancer Res (2009) 0.92
A novel model to predict the risk of readmission in patients with renal colic. J Endourol (2014) 0.92
c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J Immunol (2004) 0.92
Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study. Radiat Oncol (2010) 0.90